View in EDS HTML Full Text PDF Full Text

Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease.

Saved in:
Bibliographic Details
Title: Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease.
Authors: Boussac M; Toulouse NeuroImaging Center (ToNIC), Inserm UMR1214, University of Toulouse III, UPS, Toulouse, France., Faggianelli F; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France., Harroch E; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France., Eusebio A; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France., Fabbri M; Toulouse NeuroImaging Center (ToNIC), Inserm UMR1214, University of Toulouse III, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France., Ory-Magne F; Toulouse NeuroImaging Center (ToNIC), Inserm UMR1214, University of Toulouse III, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France., Descamps E; Toulouse NeuroImaging Center (ToNIC), Inserm UMR1214, University of Toulouse III, UPS, Toulouse, France.; CNRS, Toulouse, France., Rascol O; Toulouse NeuroImaging Center (ToNIC), Inserm UMR1214, University of Toulouse III, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France., Laurencin C; Service de Neurologie C, Hôpital Neurologique Pierre Wertheimer, Hospices civils de Lyon, Lyon, France., Marques AR; Department of Neurology, CHU Clermont-Ferrand, Université Clermont-Auvergne, IGCNC, Institut Pascal, Clermont-Ferrand, NS-Park/F-CRIN Network, France., Anheim M; Département de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg and NS-Park/FCRIN Network Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, and NS-Park/FCRIN Network Strasbourg, France.; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, and NS-Park/FCRIN Network, France., Giordana B; Service Universitaire de Psychiatrie, Hôpital Pasteur 1, CHU de Nice, Nice, France., Hopes L; Neurology Department, Nancy University Hospital, Nancy, France; NS-Park French Network., Moreau C; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France., Rolland AS; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France., Devos D; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France., Maltête D; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France., Ansquer S; Service de neurologie, CHU POITIERS; CIC INSERM 1402, CHU POITIERS, Poitiers, France., Hainque E; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, F-75013, Paris, France., Drapier S; CHU Pontchaillou, service de neurologie, CiC Inserm 1414, Rennes, France., Brandel JP; Department of Neurology, Hospital Fondation Rothschild, Paris, France., Rouaud T; Department of Neurology, CHU de Nantes, NS-Park/F-Crin network, Nantes, France., Guehl D; Service de Neurophysiologie Clinique de l'enfant et de l'adulte, Pôle des Neurosciences Cliniques, CHU de Bordeaux, Bordeaux, France.; Université de Bordeaux, Institut des Maladies Neurodégénératives (IMN, CNRS UMR5393), 33076, Bordeaux, France., Jarraya B; Pôle Neurosciences, Foch Hospital, Suresnes; Université Paris-Saclay, UVSQ, INSERM U992, CEA Paris-Saclay, Neurospin, France., Tir M; Service de Neurologie, Centre Expert de la maladie de Parkinson, CHU Amiens, Amiens, France., Witjas T; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France., Azulay JP; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France., Brefel-Courbon C; Toulouse NeuroImaging Center (ToNIC), Inserm UMR1214, University of Toulouse III, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
Corporate Authors: PREDISTIM study group
Source: Journal of Parkinson's disease [J Parkinsons Dis] 2025 Aug; Vol. 15 (5), pp. 1007-1018. Date of Electronic Publication: 2025 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-718X (Electronic) Linking ISSN: 18777171 NLM ISO Abbreviation: J Parkinsons Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1877-718X
DOI:10.1177/1877718X251354932